Liposomal doxorubicin-related palmar-plantar erthrodysesthesia (hand-and foot syndrome): Report of a case [Li·pozomal doksorubi·si·n i·le i·li·şki· li· palmar-plantar eri·trodi·sestezi· (el-ayak sendromu): Olgu sunumu ve derleme]

dc.contributor.authorŞahin Ç.
dc.contributor.authorTerek M.C.
dc.contributor.authorÖzsaran A.
dc.contributor.authorDikmen Y.
dc.contributor.authorKarabulut B.
dc.date.accessioned2019-10-26T22:15:11Z
dc.date.available2019-10-26T22:15:11Z
dc.date.issued2011
dc.departmentEge Üniversitesien_US
dc.description.abstractPalmar-plantar erthrodyesthesia (PPE) (hand and foot syndrome) is a dermatological toxic reaction related to some chemotherapeutic agents. Liposomal doxorubicin is the long-acting formula of doxorubisin and it causes PPE in 50% of the patients when used with the dosage of 50 mg/m2. The disease causes burning sensation in the hands and feet and then shows progression by edema and erythema. After the disease is estbalished the treatment consists of lowering the drug dosage, prolonging the dose intervals or discontinuing the drug as well as using topical agents.en_US
dc.identifier.endpage66en_US
dc.identifier.issn1305-4252
dc.identifier.issn1305-4252en_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage62en_US
dc.identifier.urihttps://hdl.handle.net/11454/19390
dc.identifier.volume8en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofTurk Jinekoloji ve Obstetrik Dernegi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLiposomal doxorubicinen_US
dc.subjectPalmar-plantar erthrodyesthesiaen_US
dc.titleLiposomal doxorubicin-related palmar-plantar erthrodysesthesia (hand-and foot syndrome): Report of a case [Li·pozomal doksorubi·si·n i·le i·li·şki· li· palmar-plantar eri·trodi·sestezi· (el-ayak sendromu): Olgu sunumu ve derleme]en_US
dc.typeArticleen_US

Dosyalar